Clinical Trial Update: Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining abnormal ventilatory response to CO2 as a biomarker for seizure-induced respiratory depression, and how SSRI modification may i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Sudden Unexpected Death in Epilepsy

Drugs mentioned

• SSRI

Snippet

Sponsor: Rup Kamal Sainju | Conditions: Epilepsy, SUDEP | Phase 2 | Status: COMPLETED | Results posted: 2020-05-04